GlassScriptPhysician profile
Haley M Mccarty
NPI 1124430640
$1,999.07
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.17 · 2022: $203 · 2023: $1,532 · 2024: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,769.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $1,352.14 | 2023 | M22 |
| Revance Therapeutics, INC. | $216.03 | 2024 | Daxxify |
| Novo Nordisk INC | $167.23 | 2022-2023 | Ozempic, Rybelsus |
| Abbott Laboratories | $74.62 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Mylan Specialty L.P. | $65.55 | 2022-2023 | Yupelri |
| Abbvie INC. | $40.53 | 2023 | |
| Tactile Systems Technology INC | $39.26 | 2023 | Entre Plus, Flexitouch Plus |
| Melinta Therapeutics, LLC | $17.95 | 2023 | Kimyrsa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.30 | 2022 | |
| Merck Sharp & Dohme LLC | $11.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Mccarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.